MICAL2 - microtubule associated monooxygenase, calponin and LIM domain containing 2 Gene

Also Known as MICAL-2

Species: Bos taurus

Gene Type: protein coding
Gene ID: 534041

MICAL2 Products (12)

mRNA Protein Name
XM_010812538.3 XP_010810840.2 F-actin-monooxygenase MICAL2 isoform X1
XM_010812544.3 XP_010810846.2 F-actin-monooxygenase MICAL2 isoform X5
XM_010812542.3 XP_010810844.2 F-actin-monooxygenase MICAL2 isoform X3
XM_010812543.3 XP_010810845.2 F-actin-monooxygenase MICAL2 isoform X4
XM_010812541.3 XP_010810843.2 F-actin-monooxygenase MICAL2 isoform X2
XM_005216093.4 XP_005216150.1 F-actin-monooxygenase MICAL2 isoform X9
XM_005216092.4 XP_005216149.1 F-actin-monooxygenase MICAL2 isoform X7
XM_024975804.1 XP_024831572.1 F-actin-monooxygenase MICAL2 isoform X7
XM_002693051.6 XP_002693097.1 F-actin-monooxygenase MICAL2 isoform X6
XM_010812545.3 XP_010810847.1 F-actin-monooxygenase MICAL2 isoform X6
XM_010812546.3 XP_010810848.1 F-actin-monooxygenase MICAL2 isoform X8
XM_010812547.3 XP_010810849.1 F-actin-monooxygenase MICAL2 isoform X10
Protein Preferred Names Protein Names

[F-actin]-monooxygenase MICAL2

F-actin-monooxygenase MICAL2

  • MICAL C-terminal-like protein

  • [F-actin]-methionine sulfoxide oxidase MICAL2

  • microtubule associated monoxygenase, calponin and LIM domain containing 2

  • molecule interacting with CasL protein 2

  • protein-methionine sulfoxide oxidase MICAL2

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-P0107 RC-3095 Antagonist 99.43% Phase 2

Pre-clinical Phase

Bioactive Molecules (27)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P0107A RC-3095 TFA Antagonist 99.66% Unkown
HY-103316A Ned 19 Inhibitor 99.92% Unkown
HY-12736A GSK143 dihydrochloride Inhibitor 99.37% Unkown
HY-109506S DPPC-d62 99.0% Unkown
HY-145119S Mindeudesivir 98.20% Unkown
HY-W010516 2-Methylvaleric acid 99.98% Unkown
HY-W654264 2-Methylbutyrylcarnitine chloride Activator 98.92% Unkown
HY-N1393 2-Methoxybenzoic acid Inhibitor 99.86% Unkown
HY-75625 2-Hydroxy-4-methoxybenzoic acid 99.64% Unkown
HY-109506S1 DPPC-d9 98.0% Unkown
HY-109506S3 DPPC-d9-1 ≥99.0% Unkown
HY-109506S9 DPPC-13C2 95.0% Unkown
HY-131102 Mequindox Inhibitor 99.62% Unkown
HY-N1393R 2-Methoxybenzoic acid (Standard) / Unkown
HY-101139 Xanthine amine congener Antagonist / Unkown
HY-113902 (2-(β-Piperidinoethyl)-9-hydroxyellipticinium chloride Inhibitor / Unkown
HY-12736 GSK143 Inhibitor / Unkown
HY-162720 NNRT-IN-4 Inhibitor / Unkown
HY-B0448S1 Phenytoin-15N2,13C 99.84% Unkown
HY-D0195S Acesulfame-d4 potassium 99.72% Unkown
HY-N1393S1 2-Methoxybenzoic acid-d3 / Unkown
HY-RS08426 MICAL2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-109506S2 (Rac)-DPPC-d6 98.0% Unkown
HY-B0281AS Ranitidine-d6 hydrochloride Antagonist 97.00% Unkown
HY-N1393S 2-Methoxybenzoic acid-13C6 / Unkown
HY-RS20179 Mical2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26683 Mical2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens MICAL2 NCBI NCBI:9645